| 0 (0%) | 02-21 15:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 187.21 |
1-year : | 218.67 |
| Resists | First : | 160.28 |
Second : | 187.21 |
| Pivot price | 150.14 |
|||
| Supports | First : | 148.23 |
Second : | 140.77 |
| MAs | MA(5) : | 150.31 |
MA(20) : | 150.31  |
| MA(100) : | 139.31 |
MA(250) : | 135.97 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 72 |
D(3) : | 60.6 |
| RSI | RSI(14): 59.3 |
|||
| 52-week | High : | 162.11 | Low : | 107 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ICUI ] has closed below upper band by 0.8%. Bollinger Bands are 13.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 160.07 - 160.71 | 160.71 - 161.25 |
| Low: | 141.13 - 141.84 | 141.84 - 142.46 |
| Close: | 155.69 - 156.96 | 156.96 - 158.05 |
Sat, 21 Feb 2026
ICUI: Piper Sandler Raises Price Target to $178, Maintains Overw - GuruFocus
Fri, 20 Feb 2026
ICU Medical resolves Smiths Medical warning letter, posts mixed Q4 - Drug Delivery Business
Thu, 19 Feb 2026
ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Nasdaq
Thu, 19 Feb 2026
ICUI: Organic growth, margin gains, and cash flow set to improve as integration wraps up in 2026 - TradingView
Thu, 19 Feb 2026
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Thu, 19 Feb 2026
ICU Medical's (NASDAQ:ICUI) Q4 CY2025: Beats On Revenue - Finviz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 25 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 2.8 (%) |
| Held by Institutions | 117.8 (%) |
| Shares Short | 1,150 (K) |
| Shares Short P.Month | 1,320 (K) |
| EPS | -0.32 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 86.16 |
| Profit Margin | -0.4 % |
| Operating Margin | 5 % |
| Return on Assets (ttm) | 1.9 % |
| Return on Equity (ttm) | -0.4 % |
| Qtrly Rev. Growth | -8.9 % |
| Gross Profit (p.s.) | 34.27 |
| Sales Per Share | 93.96 |
| EBITDA (p.s.) | 13.45 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 159 (M) |
| Levered Free Cash Flow | 214 (M) |
| PE Ratio | -506.55 |
| PEG Ratio | 0 |
| Price to Book value | 1.82 |
| Price to Sales | 1.67 |
| Price to Cash Flow | 24.31 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|